Literature DB >> 9540995

Gene therapy for genetic skin disease.

P A Khavari1.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9540995     DOI: 10.1038/jid.1998.3

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  5 in total

1.  Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.

Authors:  W Pfutzner; A Terunuma; C L Tock; E K Snead; T M Kolodka; M M Gottesman; L Taichman; J C Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

2.  In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.

Authors:  P B Robbins; Q Lin; J B Goodnough; H Tian; X Chen; P A Khavari
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

3.  Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.

Authors:  Christoph M Lanschuetzer; Edit B Olasz; Zelmira Lazarova; Kim B Yancey
Journal:  J Invest Dermatol       Date:  2008-11-27       Impact factor: 8.551

Review 4.  Enhancing Permeation of Drug Molecules Across the Skin via Delivery in Nanocarriers: Novel Strategies for Effective Transdermal Applications.

Authors:  Yi-Qun Yu; Xue Yang; Xiao-Fang Wu; Yi-Bin Fan
Journal:  Front Bioeng Biotechnol       Date:  2021-03-29

5.  Efficient delivery of nucleic acid molecules into skin by combined use of microneedle roller and flexible interdigitated electroporation array.

Authors:  Dong Huang; Deyao Zhao; Xiaoxia Wang; Chunhui Li; Tongren Yang; Lili Du; Zewen Wei; Qiang Cheng; Huiqing Cao; Zicai Liang; Yuanyu Huang; Zhihong Li
Journal:  Theranostics       Date:  2018-03-22       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.